The North America transcranial stimulation devices market size is expected to reach US$ 961.3 million by 2033 from US$ 374.1 million in 2025. The market is estimated to register a CAGR of 12.5% from 2026 to 2033.
Executive Summary and North America Transcranial Stimulation Devices Market Analysis:
In the face of more advanced neurotechnology ecosystems that have emerged throughout North America, there are significant changes in how clinicians incorporate transcranial stimulation devices into their therapeutic practices when dealing with neurological and neuropsychiatric conditions. Firstly, one of the important drivers in the process comes from the increasing awareness among healthcare providers about neuropsychiatric and neurodegenerative disorders and the growing demand for alternatives to medication treatment, which leads to the incorporation of such technologies by hospitals and specialty clinics for neuromodulation purposes. Secondly, the improvement in the accuracy of neurotechnologies and ease of use, both in portable and targeting terms, serves as another factor in favor of increased utilization. However, an important limitation is that many institutions face certain difficulties in adopting new technologies because of regulatory requirements and the need for adequate evidence, which leads to a slower procurement process. Collaboration between departments of neurology, psychiatry, and rehabilitation units becomes another important factor affecting the adoption process, as organizations tend to look for ways to incorporate these solutions to support care pathways for various conditions. On the other hand, changing clinical training standards and interdisciplinary skills acquisition have affected the speed of adoption, while technological improvements by manufacturers are targeting interoperability, safety, and ease-of-use to match the needs of outpatient and home settings; however, concerns about payment remain as payers evaluate cautiously despite increased awareness of neuromodulation techniques at top hospital and clinic chains within the region's leading urban health networks.
North America Transcranial Stimulation Devices Market - Strategic Insights:
Get more information on this report
North America Transcranial Stimulation Devices Market Segmentation Analysis:
Key segments that contributed to the derivation of the North America transcranial stimulation devices market analysis are product type, application, and end user.
By product type, the transcranial stimulation devices market is segmented into transcranial magnetic stimulation devices and transcranial direct current stimulation devices. The transcranial magnetic stimulation devices segment dominated the market in 2025.
Based on application, the transcranial stimulation devices market is categorized into cognitive & behavioral regulation and pain & sensory modulation. The cognitive & behavioral regulation segment dominated the market in 2025.
In terms of end user, the transcranial stimulation devices market is categorized into hospitals, specialty clinics, ambulatory surgical centers, and other end users. The hospitals segment dominated the market in 2025.
North America Transcranial Stimulation Devices Market Drivers and Opportunities:
Rising Cases of Depression and Anxiety
North American healthcare facilities have seen an increase in cases involving patients who do not exhibit sustainable recovery through traditional drug therapy and/or psychotherapy. The emergence of such cases has motivated neuromodulation clinics and hospital networks to include the use of transcranial stimulation devices as early as possible in their treatment plans, especially when symptoms remain and interfere with patients' rehabilitation and return to work.
The proceduralization of transcranial stimulation procedures within outpatient mental healthcare facilities means that the process involves the allocation of chair time, tracking of response curves, and monitoring of progress within a more structured environment, enabling providers to easily compare responses between multiple treatment episodes without depending on patients' accounts. It also facilitates the systematic mapping of targeted brain areas and consistent dose administration throughout different episodes of treatment.
Clinic administrators must also consider the new priorities of patients who wish to receive treatment outside systemic intervention, owing to the negative side effects caused by medications. In turn, healthcare providers must also take note of the efficiency in the process of using transcranial stimulation equipment, technician training needs, and billing issues.
Expansion in PTSD Treatment
Transcranial stimulators, in this case, have become more common among clinical approaches to PTSD and other anxiety disorders. Devices are recommended for use alongside exposure treatments in cases when emotional regulation processes remain uncontrolled despite structured psychological treatment programs.
The positioning of devices in such settings usually corresponds to an attempt to measure patient engagement through the metrics of adherence and physiological responses to stimulator sessions. Stimulus session protocols in this setting include the introduction of stimulation sessions before or after the patient's psychotherapy appointment in order to impact their neuroplastic readiness to undergo psychotherapy sessions.
Sharing patient data allows clinicians to develop a sequence of stimulator sessions based on the timing of their symptoms in psychotherapy sessions. At the same time, specialty clinics and trauma-focused care programs in integrated health care facilities adjust referral design based on identifying patients suffering from chronic anxiety to engage in neurostimulation. Consequently, referral design and device placement can affect how quickly neurostimulation techniques will be used for PTSD treatment.
North America Transcranial Stimulation Devices Market Size and Share Analysis:
The North America transcranial stimulation devices market demonstrates steady growth, with size and share analysis highlighting evolving trends and competitive dynamics among key players. The report examines subsegments categorized within product type, application, and end user, offering insights into their contribution to overall market performance.
By product type, the transcranial magnetic stimulation devices subsegment dominated the market in 2025, driven by its strong clinical efficacy in treating major depression and other neurological disorders, along with increasing regulatory approvals and growing adoption in hospital-based neuropsychiatric care.
Based on application, the cognitive & behavioral regulation subsegment dominated the market in 2025, driven by the rising prevalence of mental health disorders and increasing demand for non-invasive therapies that improve cognition, mood, and behavioral outcomes without pharmacological side effects.
In terms of end user, the hospitals subsegment dominated the market in 2025, driven by higher availability of advanced neurostimulation infrastructure, presence of trained specialists, and preference for supervised clinical environments for safe and effective patient treatment.
North America Transcranial Stimulation Devices Market Report Highlights:
Report Attribute
Details
Market size in 2025
US$ 374.1 Million
Market Size by 2033
US$ 961.3 Million
CAGR (2026 - 2033)
12.5%
Historical Data
2022-2024
Forecast period
2026-2033
Segments Covered
By Product Type
Transcranial Magnetic Stimulation Devices
Transcranial Direct Current Stimulation Devices
By Application
Cognitive & Behavioral Regulation
Pain & Sensory Modulation
By End User
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Other End Users
Regions and Countries Covered
North America
US, Canada, Mexico
Market leaders and key company profiles
eNeura Inc.
Neuronetics
BrainsWay Ltd.
Soterix Medical Inc.
Flow Neuroscience
Magstim
Nexstim
Neurosoft
Remed
Halo Neuroscience
Get more information on this report
North America Transcranial Stimulation Devices Market Report Coverage and Deliverables:
The "North America Transcranial Stimulation Devices Market Size and Forecast (2022-2033)" report provides a detailed analysis of the market covering below areas:
Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Market trends, as well as drivers, restraints, and opportunities
Market analysis covering key trends, global and regional framework, major players, regulations, and recent developments
Market concentration, heat map analysis, prominent players, and recent developments for the Market
Detailed company profiles, including SWOT analysis
North America Transcranial Stimulation Devices Market Geographic Insights:
The geographical scope of the North America Transcranial Stimulation Devices Market report is divided into US, Canada, and Mexico. US held the largest share in 2025.
The region of North America is known as a prime regional market for transcranial stimulation systems because the United States remains a leader in terms of the development of its neurotechnology industry, as well as clinical implementation of non-invasive brain stimulation techniques. Continuous market demands in the USA are underpinned by close cooperation between research facilities and healthcare organizations, fast adoption in the fields of psychiatry and neurology, and reimbursement practices that make non-invasive brain stimulation treatments financially feasible for hospitals and outpatient facilities alike. Canada is characterized by market expansion owing to growing focus on making mental healthcare more accessible, integration of neuromodulation techniques into the public healthcare system, and active involvement of universities and teaching hospitals in clinical trials aimed at optimizing therapy outcomes. In Mexico, the dynamics of the market will be dictated by increasing interest in private sector healthcare services, development of neurological care facilities, and growing awareness of non-invasive brain stimulation techniques among medical practitioners and patients. In addition, the high number of manufacturers, start-up ventures, and regulatory processes for stimulating technology make the market in the United States more mature than its neighboring markets due to the ease with which innovations can be brought to commercial use in the region. Knowledge exchange is also evident between North American nations, whereby knowledge related to clinical protocols and usage of the technology in question spreads through North American nations, from research centers in the United States to Canada and Mexico, thus making it possible for innovation to become more relevant in terms of health needs and costs in each country.
Get more information on this report
North America Transcranial Stimulation Devices Market Research Report Guidance:
The report includes qualitative and quantitative data in the North America Transcranial Stimulation Devices Market across product type, application, end user, and geography.
The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the North America Transcranial Stimulation Devices Market.
Chapter 3 focuses on the research methodology of the study.
Chapter 4 includes ecosystem analysis.
Chapter 5 highlights the major industry dynamics in the North America Transcranial Stimulation Devices Market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
Chapter 6 discusses the North America Transcranial Stimulation Devices Market scenario, in terms of historical market revenues, and forecast till the year 2033.
Chapters 7 to 10 cover the North America Transcranial Stimulation Devices Market segments by product type, application, end user, and geography across US, Canada, and Mexico. They cover the market revenue, forecast, and factors driving the market.
Chapter 11 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
Chapter 12 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
Chapter 13 provides detailed profiles of the major companies operating in the North America Transcranial Stimulation Devices Market. Companies have been profiled on the basis of their key facts, business descriptions, products, financial overview, SWOT analysis, and key developments.
Chapter 14, i.e., the appendix, is inclusive of a brief overview of the company, list of abbreviations, and a disclaimer.
North America Transcranial Stimulation Devices Market News and Key Development:
The North America Transcranial Stimulation Devices Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the North America transcranial stimulation devices market are:
In March 2026, Soterix Medical announced that it had received FDA clearance for its SPRY Transcranial Magnetic Stimulation (TMS) Therapy system, a next-generation transcranial stimulation platform designed for treating major depressive disorder in North American clinical settings.
In December 2024, Neuronetics announced the completion of its acquisition of Greenbrook TMS, combining NeuroStar Advanced Therapy technology with Greenbrook's network of 95 U.S. treatment clinics to significantly expand access to transcranial magnetic stimulation services across North America.
Key Sources Referred:
U.S. Food and Drug Administration (FDA)National Institute of Mental Health (NIMH)National Institute for Health and Care Excellence (NICE)European Medicines Agency (EMA)Medicines and Healthcare products Regulatory Agency (MHRA)American Psychiatric Association (APA)World Health Organization (WHO)International Neuromodulation Society (INS)International Society for Neuroregulation & Research (ISNR)European Society for Magnetic Resonance in Medicine and Biology (ESMRMB)Company WebsitesCompany Annual ReportsCompany Investor Presentations
Identical Market Reports with other Region/Countries
Krishna is a Market Research Analyst with over 4 years of experience across Life Sciences and Materials & Chemicals industries. He holds a Bachelor's degree in Pharmacy (B.Pharm.) and a Master's degree in Pharmaceutical Medicinal Chemistry (M.Pharm.). His expertise spans market intelligence, competitive benchmarking, market sizing and forecasting, primary and secondary research, and strategic consulting.
Krishna has successfully contributed to numerous syndicated and custom research engagements, delivering industry reports, market assessments, competitive analyses, and business proposals for clients across diverse sectors. With ..
Show More
Frequently Asked Questions
How big is the North America Transcranial Stimulation Devices Market?
The North America Transcranial Stimulation Devices Market is valued at US$ 374.1 Million in 2025, it is projected to reach US$ 961.3 Million by 2033.
What is the CAGR for North America Transcranial Stimulation Devices Market by (2026 - 2033)?
As per our report North America Transcranial Stimulation Devices Market, the market size is valued at US$ 374.1 Million in 2025, projecting it to reach US$ 961.3 Million by 2033. This translates to a CAGR of approximately 12.5% during the forecast period.
What segments are covered in this report?
The North America Transcranial Stimulation Devices Market report typically cover these key segments-
Product Type (Transcranial Magnetic Stimulation Devices, Transcranial Direct Current Stimulation Devices)
End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End Users)
What is the historic period, base year, and forecast period taken for North America Transcranial Stimulation Devices Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Transcranial Stimulation Devices Market report:
Historic Period : 2022-2024
Base Year : 2025
Forecast Period : 2026-2033
Who are the major players in North America Transcranial Stimulation Devices Market?
The North America Transcranial Stimulation Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
eNeura Inc.
Neuronetics
BrainsWay Ltd.
Soterix Medical Inc.
Flow Neuroscience
Magstim
Nexstim
Neurosoft
Remed
Halo Neuroscience
Who should buy this report?
The North America Transcranial Stimulation Devices Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the North America Transcranial Stimulation Devices Market value chain can benefit from the information contained in a comprehensive market report.
Get Free Sample For North America Transcranial Stimulation Devices Market
